http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
-
Acutus Medical Announces Preliminary Unaudited First Quarter 2023 Results
-
RECOVER AF Study Reports 91% of First Redo Patients Achieved Freedom from AF at One Year After AcQMap-guided Ablation Therapy
-
Late-Breaking ACQFORCE FLUTTER Trial Meets Primary Endpoint for Safety and Efficacy with the First Gold-Tipped Contact Force Sensing Ablation Catheter
-
Acutus Medical Announces Acceptance of the AcQForce Flutter Abstract for Presentation during the Late-Breaking Clinical Trials and First Report Investigations sessions at the 2023 AF Symposium
-
Acutus Medical Announces Full Market Release of next generation software platform AcQMap 8.5
-
Acutus Medical Obtains MDR CE Mark of the AcQMap 3D Imaging and Mapping Catheter
-
BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory Council
-
BrightInsight Adds Medical Device and Biopharmaceutical Experts, Tamara Elias, M.D., and Scott Huennekens to Advisory Council
-
Acutus Medical (AFIB) Announces Approval of its AcQMap System and AcQMap 3D Imaging and Mapping Catheter in Japan
-
Acutus Medical Announces Approval of its AcQMap System and AcQMap 3D Imaging and Mapping Catheter in Japan
-
Acutus Medical Announces FDA Clearance, Commercial Launch of AcQCross™ Line Extension Compatible with Watchman™ Delivery System
-
Acutus Medical completes enrollment in IDE trial with its AcQBlate® FORCE Sensing Ablation System
-
Acutus Medical’s Pulsed Field Ablation System To Be Featured During 27th Annual AF Symposium
-
Acutus Medical Initiates CE Mark Study for Focal Pulsed Field Ablation Therapy to Treat Atrial Fibrillation
-
Acutus Medical (AFIB) Appoints Niamh Pellegrini to its Board
-
Acutus Medical Appoints Niamh Pellegrini to Board of Directors
-
Acutus Medical's (AFIB) Innovative Suite of Software Upgrades Receives FDA Clearance and CE Mark
-
AcQMap 8, Acutus Medical’s Innovative Suite of Software Upgrades, Receives FDA Clearance and CE Mark
-
HRS 2021: EP Experts to Demonstrate the Benefits of Acutus Medical’s Complete Suite of EP Technologies
-
AliveCor and Acutus Medical Partner to Evaluate Management and Treatment of Cardiac Arrhythmias
-
Acutus Medical (AFIB) Receives FDA Approval to Initiate US Atrial Fibrillation IDE Trial with the AcQBlate® FORCE Sensing Ablation System
-
Acutus Medical Receives FDA Approval to Initiate US Atrial Fibrillation IDE Trial with the AcQBlate® FORCE Sensing Ablation System
-
Acutus Medical (AFIB) Announces CE Mark Approval for Suite of Next Generation EP Products in Europe
-
Acutus Medical Announces CE Mark Approval for Suite of Next Generation EP Products in Europe
-
Acutus Medical (AFIB) Announces FDA Clearance of AcQCross, a Full Suite of Universal Transseptal Crossing Devices
-
Acutus Medical Announces FDA Clearance of AcQCross™, a Full Suite of Universal Transseptal Crossing Devices
-
Acutus Medical (AFIB) Initiates First IDE Therapy Trial with the AcQBlate® FORCE Sensing Ablation System
-
Acutus Medical Initiates First IDE Therapy Trial with the AcQBlate® FORCE Sensing Ablation System
-
Acutus Medical Board Appoints John Sheridan as a New Director
-
Acutus Medical (AFIB) Receives Vizient Innovative Technology Contract
-
Acutus Medical Appoints Duane Wilder as Chief Commercial Officer
-
Acutus Medical Receives Vizient Innovative Technology Contract
-
Acutus Medical (AFIB) Appoints New Chief Financial Officer and New Board Member
-
Acutus Medical, Inc. Appoints New Chief Financial Officer and New Board Member
-
Acutus Medical Suite of EP Products To Be Featured During Recorded Cases at AF Symposium 2021
-
Acutus Medical Announces CE Mark and European Launch of AcQCross™ Transseptal System, a Fully Integrated Family of Transseptal Crossing Products
-
Acutus Medical Launches AcQBlate® Force Sensing Ablation System in Europe
-
Steven Mickelsen, MD, Joins Acutus Medical as Chief Translational Science Officer

